Black Titan Corp Settles Ex-CEO Claim with Dilutive Preferred Shares; Amends $200M Convertible Note Terms
summarizeSummary
Black Titan Corp settled a former CEO's claim for $800,000 by issuing dilutive preferred shares to a major investor and updated terms for a massive $200 million convertible note program, all while its stock is near 52-week lows.
check_boxKey Events
-
Settlement with Former CEO
The company paid $800,000 to former CEO Mr. Lazar to resolve a dispute over a special bonus related to the October 2025 merger.
-
Dilutive Preferred Share Issuance
To fund the settlement, Black Titan issued 800 Series B convertible preferred shares to ARC Group International, a significant shareholder. These shares are convertible at a 20% discount to the 5-day VWAP and include strong protective provisions for the holder.
-
Convertible Note Program Amendments
The company amended its $200 million convertible note program from January 2026, removing references to an "Adjusted Floor Price" and confirming a fixed floor price of $0.3248 for conversions.
-
Trading Near 52-Week Lows
These significant dilutive capital activities are occurring while the company's stock is trading near its 52-week low of $1.21.
auto_awesomeAnalysis
Black Titan Corp has settled a dispute with its former CEO for $800,000, funding the payment by issuing convertible preferred shares to a significant shareholder. These Series B preferred shares come with a 20% conversion discount and grant the holder significant protective rights, indicating a highly dilutive and potentially unfavorable capital raise for existing shareholders. Concurrently, the company amended terms for its previously disclosed $200 million convertible note program, solidifying a low conversion floor price of $0.3248. These capital activities, occurring while the stock trades near its 52-week low, signal ongoing significant dilution and financial strain.
At the time of this filing, BTTC was trading at $1.23 on NASDAQ in the Technology sector, with a market capitalization of approximately $11.2M. The 52-week trading range was $1.21 to $39.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.